Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux.
Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate.
Newer concepts of blood coagulation.
Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin.
"Normal" thrombin generation.
Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.
Future possibilities in the regulation of the extrinsic pathway: rFVIIa and TFPI.
Tissue factor pathway inhibitor and the revised theory of coagulation.
Tissue factor pathway inhibitor and the current concept of blood coagulation.
Prescribing Info - Questions - Drug Info - Links - PDA Software - Article Summaries - Slideshows - Review Articles - What's New
© Copyright 1999-2019 All Rights Reserved.